Abstract
Epigallocatechin-3-gallate (EGCG) is one of the major polyphenolic compounds present in green tea extracts and has been used as a potential drug for the treatment of numerous diseases. The present study aimed to elucidate the role and mechanism of EGCG in protecting against H2O2-induced apoptosis in mouse vascular smooth muscle cells (VSMCs). VSMCs were pretreated with various concentrations of EGCG for 2 hours prior to treatment with H2O2. Treatment with H2O2 significantly decreased the cell viability and induced apoptosis of VSMCs, which were attenuated by pretreatment with EGCG. In particular, EGCG pretreatment significantly inhibited the H2O2-induced upregulation of cleaved forms of caspase-3, caspase-8, and caspase-9, Bax, CathepsinD, and downregulation of Bcl-2. Moreover, the antioxidation effect of EGCG on VSMCs was determined to be associated with the 67kD laminin receptor (67LR). Our results demonstrated that EGCG improved cell viability and protected VSMCs against oxidative stress through both extrinsic and intrinsic pathways, while 67LR is likely to be an active and key receptor of EGCG. These findings provide a novel molecular mechanism of EGCG in inhibiting H2O2-induced apoptosis in VSMCs, as well as its function in preventing the development of atherosclerosis.
Similar content being viewed by others
Introduction
Cardiovascular disease (CVD) remains the major cause of morbidity and mortality worldwide1. There are several risk factors that contribute to the increased prevalence of CVD including atherosclerosis, which is responsible for nearly half of all deaths in developed countries2. Indeed, complications as a result of atherosclerosis can often lead to the increased morbidity and mortality of cardiovascular diseases in general3. Therefore, it is important to explore the mechanisms involved in the development of atherosclerosis in order to prevent its occurrence. Atherosclerosis is a typical multifactorial disease, which is dependent on the formation of early atherosclerotic lesions, as well as the oxidative stress and apoptosis of Vascular smooth muscle cells (VSMCs)4. VSMCs are located in the medial layer of blood vessels, and are the main type of cell present in the artery5. The abnormal apoptosis of VSMCs is associated with numerous pathologies such as inflammation, calcification and thrombosis6. Therefore, inhibiting the apoptosis of VSMCs can be an effective preventive strategy in slowing down the generation of plaque and development of atherosclerosis. Hydrogen peroxide (H2O2), a highly reactive oxygen species (ROS), gives rise to wide spread oxidative damage, and has been widely used to mimic oxidative stress in vitro 7. Previous studies have demonstrated that H2O2 may also activate apoptosis in vivo 8. The mitochondria-mediated intrinsic pathway and the cell death receptors-mediated extrinsic pathway are the main pathways involved in cell apoptosis9. These pathways activate distinct apical caspases (caspase-8 or caspase-9) and consequently activate the common downstream executioner caspase-310. Moreover, expression of Bcl-2 has been identified as an important marker of anti-apoptosis in the intrinsic pathway11.
Green tea is one of the most popular beverages worldwide, and has long been known to possess various beneficial biological functions12. Among the numerous polyphenols that have been isolated from green tea, such as epicatechin (EC), epicatechin-3-gallate (ECG), epigallocatechin (EGC) and epigallocatechin-3-gallate (EGCG), EGCG has been demonstrated to be the main biologically active substance in green tea13. Previous epidemiological studies had demonstrated that consumption of green tea was associated with a reduction in the prevalence, as well as the morbidity and mortality associated with numerous diseases such as diabetes, hypertension, cardiovascular disease and various types of cancers14,15,16,17,18. Previous studies have demonstrated that the green tea extract EGCG protected cardiomyocytes against ischemia/reperfusion-induced apoptosis both in vivo and in vitro 19. EGCG had also been demonstrated to reduce blood pressure and improve endothelial function in hypertensive rats20. In addition, EGCG significantly inhibited atherosclerosis in rabbits21, while EGCG was also shown to inhibit ox-LDL induced vascular endothelial dysfunction22. Furthermore, EGCG was demonstrated to inhibit various different intracellular pathways, leading to pro-apoptotic and cytotoxic effects in tumor cells20. However, little is known about the molecular mechanisms of EGCG’s anti-oxidative activity in H2O2-induced apoptosis in VSMCs.
The membrane bound 67-kDa laminin receptor (67LR) is a non-integrin cell surface receptor and is frequently over-expressed in tumor cells23. 67LR had been previously identified as a cell surface receptor of EGCG in cancer cells, and played a key role in cancer protection13. Moreover, 67LR was shown to act as a cancer-specific cell death receptor, and mediated the apoptotic signaling pathway in multiple myeloma cell24. Despite the importance of 67LR in regulating EGCG activity in cancer cells, the underlying mechanisms of 67LR as an active receptor of EGCG in mouse VSMCs remains unclear.
In the present study, we examined the role of EGCG in preventing H2O2-induced apoptosis of VSMCs and verified the role of 67LR as an active and key receptor of EGCG required for preventing H2O2-induced apoptosis in VSMCs.
Results
Effect of EGCG and H2O2 on cell viability of VSMCs
We first examined the antioxidation effect of EGCG following H2O2-induced oxidative stress using mouse primary VSMCs. The cytotoxic effect of EGCG on VSMCs was determined by treatment with different concentrations (10 μM, 50 μM, 100 μM and 150 μM) of EGCG. There were no significant differences in cell viability between the treatment groups and the control group, which indicated that EGCG had no cytotoxic effect on VSMCs (Fig. 1A). We further determined the concentration-dependent effect of H2O2 in inducing oxidative stress in VSMCs by treatment with 0 μM, 50 μM, 100 μM, 200 μM, 400 μM or 800 μM H2O2 for 30 min, respectively. There was a significant dose-dependent decrease in cell viability following incubation with different concentrations of H2O2 for 30 min. When cells were incubated with 200 μM H2O2, cell viabilities were attenuated by 50% compared with the control group (Fig. 1B). Hence, 200 μM H2O2 was selected as the appropriate concentration for inducing oxidative stress in VSMCs in the subsequent experiments.
The protective effect of EGCG on H2O2-induced apoptosis
We further performed Annexin V-FITC/PI assay to determine whether H2O2 could also induce VSMCs apoptosis. Following treatment with 200 μM H2O2 for 30 min, the proportion of apoptotic cells was approximately double that of untreated VSMCs, which demonstrated that H2O2 successfully induced VSMCs apoptosis (Fig. 2A,B). We therefore investegated whether EGCG pretreatment could protect against H2O2-induced apoptosis. Annexin V-FITC/PI assay was also utilized to determine the rate of apoptosis based on the sum of early and late apoptosis events. Pretreatment with different concentrations of EGCG significantly decreased the rate of apoptosis induced by 200 μM H2O2. In particular, pretreatment with 100 μM and 150 μM EGCG almost completely attenuated the rate of H2O2-induced apoptosis in VSMCs (Fig. 2A,B). Taken together, these results suggested that EGCG had a strong protective effect on H2O2-induced apoptosis, in a concentration-dependent manner.
Role of cleaved caspase-3, cleaved caspase-8, cleaved caspase-9, Bcl-2, Bax and Cathepsin D in H2O2-induced apoptosis
We next examined the expression levels of key proteins involved in apoptosis signaling pathway to determine the underlying molecular mechanisms of EGCG in protecting VSMCs from H2O2-induced apoptosis. The activation of the caspase family were detected by using antibodies specific for the cleaved form of caspase-3, caspase-8 and caspase-9. H2O2 treatment significantly increased the expression levels of cleaved form of caspase-3, caspase-8 and caspase-9, which indicated that H2O2 activated the extrinsic apoptosis pathway signaling pathway. Moreover, the expression levels of cleaved caspase-3, cleaved caspase-8 and cleaved caspase-9 were attenuated by pretreatment with EGCG (50, 100, and 150 μM), to almost the level of untreated control group (Fig. 3A). Furthermore, H2O2 treatment significantly increased the expression levels of Bax and CathepsinD, and decreased the expression of Bcl-2 compared with the control group, which were reversed by pretreatment with EGCG (Fig. 3B). These results suggested that the protective effect of EGCG against H2O2-induced apoptosis is likely mediated by the caspase family and mitochondrial apoptotic signaling pathways.
Effect of EGCG on H2O2-induced changes of 67LR
We also investigated whether there were changes in the expression of 67LR, as an active receptor of EGCG, following H2O2-induced apoptosis in VSMCs. Immunofluorescence microscopy revealed that 67LR was abundantly expressed on the surface of VSMCs in the untreated control group. However, H2O2 treatment significantly inhibited 67LR expression, which was effectively prevented by pretreatment with EGCG in a concentration-dependent manner (Fig. 4A). Furthermore, western blot analysis revealed that the protein expression level of 67LR following H2O2-induced apoptosis was consistent with our previous results (Fig. 4B). Thus, these results suggested that 67LR is down regulated to a lesser extend with increasing EGCG concentration in VSMCs.
The protective effects of EGCG on H2O2-induced apoptosis following shRNA silencing of 67LR
To further verify that 67LR was an active receptor of EGCG required for its protection against H2O2-induced apoptosis, we utilized lentivirus mediated RNAi technology to silence 67LR in VSMCs. Firstly, the 67LR short hairpin RNA (shRNA) targets (sh67LR-1 and sh67LR-2) were cloned into the lentivirus vectors, and subsequently the lentivirus packing plasmids and vector plasmids which target 67LR were co-transfected into 293 T cells. The transfection efficiency of sh67LR-1 and sh67LR-2 were greater than 80% and 90%, respectively (Fig. 5A). Next, VSMCs were infected with lentivirus which expressed either the 67LR targeted shRNA or a scrambled control shRNA. Western blot analysis confirmed that the expression levels of 67LR were significantly decreased by 75% and 95% following transfection with sh67LR-1 and sh67LR-2, respectively, compared to the scrambled control shRNA (Fig. 5B).
Additionally, following shRNA silencing of 67LR, VSMCs treated with H2O2 had significantly increased levels of cleaved caspase-3, cleaved caspase-8 and cleaved caspase-9 expression, but was not inhibited by pretreatment with EGCG (Fig. 6A). Moreover, following shRNA silencing of 67LR, pretreatment with EGCG also did not reverse the H2O2-induced changes in Bcl-2, Bax and CathepsinD expressions (Fig. 6B). Taken together, these results revealed that 67LR is likely to be an active receptor of EGCG required for its protection against H2O2-induced apoptosis in VSMCs.
Discussion
EGCG’s ability to protect against atherosclerosis is often associtated with its antioxidative, anti-inflammatory, antiproliferative, antimigration, and antithrombotic properties on VSMCs25. Atherosclerosis is a multifactorial cardiovascular disease, which can arise due to oxidative stress and formation of early atherosclerotic lesions. Oxidative stress plays an important role in the pathogenesis of atherosclerosis by promoting plaque formation26. Oxidative stress has been shown to stimulate the proliferation, migration and apoptosis of VSMCs during atherosclerosis27. Therefore, elucidating the potent antioxidant effect of EGCG on H2O2-induced apoptosis in VSMCs is important for the prevention of oxidative stress-induced apoptosis.
We first investigated the effect of EGCG on cell viability in VSMCs. There were no significant differences in cell viability between the treatment groups and the control group, which indicated that EGCG had no cytotoxic effect on VSMCs. Pretreatment with EGCG for 48 h prior to H2O2 treatment significantly improved the survival of mouse muscle cells28. However, a previous study revealed the dose-dependent decrease of cell viability following treatment with high concentrations of EGCG (1050 μM) in VSMCs29. H2O2 has been shown to decrease cell ability and induce cell apoptosis in VSMCs30. Thus, in the present study, we used H2O2 treatment for 30 min to establish the apoptosis model in VSMCs.
Apoptosis is mediated by both extrinsic and intrinsic pathways and plays key roles in maintaining normal cell physiology31. Inadequate, excessive, or inappropriate apoptosis can all contribute to disease occurrence. H2O2 induces severe intracellular oxidative stress, which leads to widespread intracellular damage and apoptosis32. In the present study, we demonstrated that the apoptosis rate of VSMCs increased significantly following H2O2 treatment, which was significantly attenuated by pretreatment with 10 μM-150 μM EGCG. EGCG was shown to regulate the apoptotic process in different ways depending on the concentration, type of cell or pathological process33. In the present study, we showed that the EGCG-mediated decrease in VSMCs apoptosis was due to the decreased expression of cleaved form of caspase-3, caspase-8 and caspase-9. The caspase family are activated by cleavage at specific aspartic residues following external stimuli, thereby resulting in apoptosis34. The intrinsic apoptosis pathway is involved in the transduction of apoptotic stimuli, such as hypoxia, oxidative stress, DNA damage, inadequate nutrients and chemical toxins, which ultimately triggers the release of anti-apoptotic proteins35. Apoptotic signals are transduced to the mitochondria through two classes of anti-apoptotic Bcl-2 proteins36. We showed that pretreatment with EGCG resulted in the decreased expression of Bax and CathepsinD, as well as the increased expression of Bcl-2. EGCG could affect apoptosis by modulating the level of expression of anti-apoptotic Bcl-2 or pro-apoptotic Bax protein37, 38. EGCG has been shown to attenuate oxidative stress in human VSMCs via activation of heme oxygenase-139. In addition, EGCG can relieve oxidative stress by inhibiting endothelin-1-stimulated generation of C-reactive protein in VSMCs40. In the present study, we demonstrated that EGCG strongly protected against H2O2-induced VSMCs apoptosis via activation of caspase family and Bcl-2 signaling pathways. These results revealed that EGCG could modulate both the extrinsic and intrinsic apoptotic pathways by decreasing the expression of cleaved caspase-3, caspase-8, caspase-9, Bax, and CathepsinD, while increasing the expression of Bcl-2.
67LR was shown to be expressed on the surface of normal cells, but overexpressed in several cancer cells41. 67LR acted as an EGCG receptor and exerts an inhibitive effect on cancer cell growth42. This suggests that EGCG may specifically target cancer cells. However, in our present study, we showed that 67LR was abundantly expressed on the surface of VSMCs, which to our knowledge had never been previously reported. The expression of 67LR was significantly decreased following H2O2 treatment, but was down regulated to a lesser extent with increasing EGCG concentration. Previous evidence has suggested that the potential action of EGCG in the prevention of cardiovascular diseases is mediated by 67LR43. Therefore, we proposed that 67LR plays a key role in EGCG-mediated H2O2-induced apoptosis in VSMCs. Lentivirus mediated RNAi technology was used to silence 67LR in VSMCs. After silencing, VSMCs treated with H2O2 had significantly increased levels of cleaved caspase-3, cleaved caspase-8 and cleaved caspase-9 expression, but was not inhibited by pretreatment with EGCG compared with H2O2 group. Furthermore, pretreatment with EGCG also did not reverse the H2O2-induced changes in Bcl-2, Bax and CathepsinD expressions. These results indicated that 67LR acts as an active receptor of EGC, thereby mediating the apoptosis signaling pathway in VSMCs.
In summary, we demonstrated that the protective effect of EGCG on H2O2-induced VSMCs apoptosis was due to the inhibition of caspase family and Bcl-2 signaling pathways, and was mediated by 67LR, a key active receptor of EGCG. Our results also suggested that the consumption of catechins found in green tea is beneficial for the prevention of atherosclerosis and cardiovascular diseases.
Methods
Antibodies
Primary antibody against caspase-3 was obtained from Santacruz biotechnology (CA, USA) (#SC-7148). Primary antibodies against caspase-8 (#13423-1-AP), caspase-9 (#10380-1-AP), Bcl-2 (#12789-1-AP), Bax (#50599-2-Ig), CathepsinD (#21327-1-AP), 67LR (#14533-1-AP), GAPDH (#10494-1-AP) and β-actin (#20536-1-AP) were purchased from Proteintech (Chicago, IL, USA). Anti-rabbit secondary antibodies (#SA00001-1) and anti-mouse secondary antibodies (#SA00001-1) were also purchased from Proteintech (Chicago, IL, USA).
Chemicals and reagents
Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Hyclone (#SH30243.01, Logan, USA) and fetal bovine serum (FBS) was purchased from Gibco (#10099141, New York, USA). Penicillin-Streptomycin Solution was purchased from Hyclone ((#SV30010, Logan, USA). EGCG was obtained from Sigma-Aldrich(#E4268, MO, USA). H2O2 was purchased from Sangon Biotech (#H1976-500ml, Shanghai, China). Cell Counting Assay kit-8 (CCK-8) was purchased from Dojindo Molecular Technologies (#CK04, MD, Japan). Annexin V-FITC/PI apoptosis assay kit was purchased from CW biotech (#CW2574S, Beijing, China).
Cell culture and treatment
VSMCs were separated from abdominal aorta of mice and the subculture cells at passages 3–8 were used in all the experiments. VSMCs were cultured in DMEM supplemented with 10% FBS and 1% penicillin and streptomycin in a humidified chamber with 5% CO2 at 37 °C. VSMCs were pre-treated with 0 μM, 10 μM, 50 μM, 100 μM or 150 μM EGCG for 2 h, washed with PBS two times and then exposed to 200 μM H2O2 for 30 min in serum-free DMEM. All experiments were performed 5 times. All animal procedures were performed according to approved protocols from the Institutional Animal Care and Use Committee of Tongji University.
Cell viability assay
Cell viability was measured using Cell Counting Assay Kit-8 (CCK-8), according to the manufacturer’s instructions. Briefly, 100 μl of VSMCs were seeded into 96-well plates at a density of 1 × 104 cells/well for 24 h, and then treated with different concentrations of EGCG for 2 h at 37 °C. Finally, the absorbance at 450 nm in each well was measured using Microplate Reader (Thermo Fisher Scientific, Inc., Waltham, MA, USA), prior to incubation with 10 μl CCK-8 solution for 3 h. Similarly, 0 μM, 50 μM, 100 μM, 200 μM, 400 μM or 800 μM H2O2 were added per well to determine the effect of H2O2 on cell viability. Results were represented as the percentage of the control group.
Apoptosis detection
VSMCs apoptosis was detected using Annexin V-FITC/PI Apoptosis Detection Kit, according to the manufacture’ protocols. Briefly, VSMCs were cultured in 6-well plates at a density of 1 × 105 cells/well at 37 °C and harvested by EDTA free trypsin for 2 min. Cells were then centrifuged at 1000 × g for 3 min, and washed twice with ice cold PBS prior to resuspension in 250 μl Binding Buffer. VSMCs were incubated with 5 μl Annexin V/FITC and 10 μl PI for 15 min in the dark at room temperature. BD Biosciences FACSCalibur flow cytometer (Franklin Lakes, NJ, USA) was used to analyze the stained samples. Results were represented as the sum percentage of early apoptosis and advanced apoptosis.
Western blot analysis
Total cell lysates were extracted using ice cold lysis buffer containing 1% phenylmethylsulfonyl fluoride (PMSF). Cells were centrifuged at 12000 × g for 15 min at 4 °C and the resulting supernatants were collected. Total protein concentrations were determined using Bicinchoninic Acid (BCA) kit (Beyotime, Shanghai, China). Protein samples were separated on 10% SDS-PAGE gels and then transferred onto Polyvinylidene-Fluoride (PVDF) membranes (Milipore, MA, USA) with transfer buffer. PVDF membranes were then blocked using 5% non-fat dry milk in Tris-buffered saline containing 1% Tween-20 (TBST) for 1 h at room temperature, then washed 3 times with TBST prior to incubation with primary antibody at 4 °C overnight. Following washing, the membranes were incubated with secondary antibody at room temperature for 1 h. After washing for 3 times with TBST, enhanced chemiluminescence was used to detect the proteins immunoreactive bands. The images were analyzed using Image J. All original full length Western Blot pictures were presented in the Supplemental Figure 1 to Supplemental Figure 4.
Immunocytochemistry (ICC)
VSMCs cells were fixed with 4% paraformaldehyde for 20 min and rinsed three times with PBS. Subsequently, cells were incubated with blocking solution (PBS containing 1% bovine serum albumin, 0.4% Triton X-100 and 4% normal goat serum) for 60 min, and then incubated with primary anti-67LR antibody (1:1000) at 4 °C overnight. After washing twice, VSMCs were incubated with Alexa Flouor-488 conjugated secondary antibody (Invitrogen, Carlsbad, CA) (1:600, goat anti-rabbit) for 1 h at room temperature. Finally, cells were washed 3 times with PBS, then counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories Inc, Burlingame, CA). The expression of 67LR was examined using a fluorescence microscope (OLYMPUS, Japan).
Lentiviral infection
The 67LR-targeted ShRNA-67LR-1 and ShRNA-67LR-2 sequences were obtained from Sigma-Aldrich (Table 1). The shRNA-67LR sequences were ligated into the PLVX-shRNA2 vector, which expressed a classic scrambled shRNA and green fluorescent protein (ZsGreen). For viral packaging, 293 T cells were cotransfected with lentiviral plasmids using Lipofectamine 2000 (Invitrogen, CA, USA) to generate the recombinant lentivirus. Cell transfection efficiency was observed using fluorescence microscopy after collection of virus supernatant. VSMCs were infected with virus supernatant and the extent of 67LR knockdown was determined using western blot analysis. shRNA-scrambled plasmid was used as a control.
Statistical analysis
All experimental data were expressed as mean ± S.D. Variables between groups were compared using one-way ANOVA, and Tukey’s test for multiple comparisons. Differences were considered to be statistically significant when p < 0.05.
References
Townsend, N. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 37, 3232–3245 (2016).
Tedgui, A. & Mallat, Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 86, 515–581 (2006).
Patel, J., Channon, K. M. & McNeill, E. The downstream regulation of chemokine receptor signalling: implications for atherosclerosis. Mediators of inflammation. 2013, 459–520 (2013).
Bennett, M. R., Sinha, S. & Owens, G. K. Vascular Smooth Muscle Cells in Atherosclerosis. Circulation research. 118, 692–702 (2016).
Ross, R. Atherosclerosis–an inflammatory disease. N Engl J Med. 340, 115–126 (1999).
Littlewood, T. D. & Bennett, M. R. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol. 14, 469–475 (2003).
Song, Q., Gou, W. L. & Zhang, R. FAM3A Protects HT22 Cells Against Hydrogen Peroxide-Induced Oxidative Stress Through Activation of PI3K/Akt but not MEK/ERK Pathway. Cell Physiol Biochem. 37, 1431–1441 (2015).
Liu, X. R. et al. Propofol attenuates H2O2-induced oxidative stress and apoptosis via the mitochondria- and ER-medicated pathways in neonatal rat cardiomyocytes. Apoptosis. 22, 639–646 (2017).
Lee, Y. & Gustafsson, A. B. Role of apoptosis in cardiovascular disease. Apoptosis. 14, 536–548 (2009).
Whelan, R. S., Kaplinskiy, V. & Kitsis, R. N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol. 72, 19–44 (2010).
Hengartner, M. O. The biochemistry of apoptosis. Nature. 407, 770–776 (2000).
Gan, R. Y., Li, H. B., Sui, Z. Q. & Corke, H. Absorption, Metabolism, Anti-Cancer Effect and Molecular Targets of Epigallocatechin Gallate (EGCG): An Updated Review. Crit Rev Food Sci Nutr. 19, 1–18 (2016).
Yamada, S. et al. Epigallocatechin-3-O-gallate up-regulates microRNA-let-7b expression by activating 67-kDa laminin receptor signaling in melanoma cells. Sci Rep. 6, 19225 (2016).
Yang, C. S., Zhang, J., Zhang, L., Huang, J. & Wang, Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res. 60, 160–174 (2016).
Potenza, M. A. et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab. 292, E1378–1387 (2007).
Peters, U., Poole, C. & Arab, L. Does Tea Affect Cardiovascular Disease? A Meta-Analysis. Am J Epidemiol. 154, 495–503 (2001).
Kurahashi, N. et al. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol. 167, 71–77 (2008).
Hong, Z. et al. Improving the effectiveness of (−)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid. J Agric Food Chem. 62, 12603–12609 (2014).
Townsend, P. A. et al. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion- induced apoptosis. FASEB J. 18, 1621–1623 (2004).
Yang, C. S., Wang, X., Lu, G. & Picinich, S. C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 9, 429–439 (2009).
Chen, L. & Zhang, H. Y. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules. 12, 946–957 (2007).
Yin, J., Huang, F., Yi, Y., Yin, L. & Peng, D. EGCG attenuates atherosclerosis through the Jagged-1/Notch pathway. Int J Mol Med 37, 398–406 (2015).
Nelson, J. et al. The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep. 28, 33–48 (2008).
Kumazoe, M. et al. 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J Clin Invest. 123, 787–799 (2013).
Stangl, V., Dreger, H., Stangl, K. & Lorenz, M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res. 73, 348–358 (2007).
Cai, H. & Harrison, D. G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 87, 840–844 (2000).
Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B. & Drexler, H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 91, 7A–11A (2003).
Dorchies, O. M., Wagner, S., Buetler, T. M. & Ruegg, U. T. Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (−)-epigallocatechin gallate. Biofactors. 35, 279–294 (2009).
Han, D. W. et al. Selective Inhibitory Effect of Epigallocatechin-3-gallate on Migration of Vascular Smooth Muscle Cells. Molecules. 15, 8488–8500 (2010).
Stridh, H., Kimland, M., Jones, D. P., Orrenius, S. & Hampton, M. B. Cytochrome c release and caspase activation in hydrogen peroxide- and tributyltin-induced apoptosis. FEBS Lett. 429, 351–355 (1998).
Whelan, R. S., Kaplinskiy, V. & Kitsis, R. N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol. 72, 19–44 (2010).
von Harsdorf, R., Li, P. F. & Dietz, R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation. 99, 2934–2941 (1999).
Giovannini, C. et al. apoptosis in cancer and atherosclerosis: polyphenol activities. Ann Ist Super Sanita. 43, 406–441 (2007).
Fuchs, Y. & Steller, H. Programmed cell death in animal development and disease. Cell. 147, 742–758 (2011).
Scorrano, L. et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell. 2, 55–67 (2002).
Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 9, 47–59 (2008).
Nam, S., Smith, D. M. & Dou, Q. P. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis. Cancer Epidemiol Biomarkers Prev. 10, 1083–1088 (2001).
Tinhofer, I. et al. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J. 15, 1613–1615 (2001).
Liu, P. L., Liu, J. T., Kuo, H. F., Chong, I. W. & Hsieh, C. C. Epigallocatechin gallate attenuates proliferation and oxidative stress in human vascular smooth muscle cells induced by interleukin-1beta via heme oxygenase-1. Mediators Inflamm. 2014, 523684 (2014).
Wang, C. J., Liu, J. T. & Guo, F. (−)-epigallocatechin gallate inhibits endothelin-1-induced C-reactive protein production in vascular smooth muscle cells. Basic Clin Pharmacol Toxicol. 107, 669–675 (2010).
Britschgi, A., Simon, H. U., Tobler, A., Fey, M. F. & Tschan, M. P. Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2. Br J Haematol. 149, 55–64 (2010).
Tachibana, H., Koga, K., Fujimura, Y. & Yamada, K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol. 11, 380–381 (2004).
Wang, Z. M. et al. Green tea polyphenol epigallocatechin-3-gallate inhibits TNF-alpha-induced production of monocyte chemoattractant protein-1 in human umbilical vein endothelial cells. Cell Physiol Biochem. 33, 1349–1358 (2014).
Acknowledgements
This work was supported by the Nature Science Foundation of China (NO. 81471402, 81300779), the National Key Basic Research Program of China (NO. 2013CB531100) and the Fundamental Research Funds for the Central Universities.
Author information
Authors and Affiliations
Contributions
X.S., Y.L. and J.L. conceived the study. X.Y. performed the experiments and wrote the paper. H.Y., W.W., C.W., Y.Y. and Y.H. performed the data analysis. Y.L., X.S. and J.L. participated in the criticall reviewed the manuscript. X.S. and J.L. had primary responsibility for the final content. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yan, X., Li, Y., Yu, H. et al. Epigallocatechin-3-gallate inhibits H2O2-induced apoptosis in Mouse Vascular Smooth Muscle Cells via 67kD Laminin Receptor. Sci Rep 7, 7774 (2017). https://doi.org/10.1038/s41598-017-08301-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-08301-6
This article is cited by
-
Caloric restriction-mimetics for the reduction of heart failure risk in aging heart: with consideration of gender-related differences
Military Medical Research (2022)
-
(−)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats
Scientific Reports (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.